For research and educational purposes only. Not medical advice.
Thymosin Beta-4 Reference
Educational, not medical advice reference for Thymosin Beta-4: Recovery; regulatory status, evidence posture, source review, and schedule notes. Also known a…
Reference summary
The literature is a mix of animal regeneration studies and newer translational cardiac work, including a small placebo-controlled STEMI trial. TB-500 marketing claims still extrapolate from full-length Tbeta4 rather than a settled human TB-500 evidence base.
- Categories
- Recovery
- Aliases
- Thymosin beta-4, TB4, TB4 full peptide
- Evidence posture
- translational — Human translational data are narrow and do not establish a general recovery protocol.
- Regulatory status
- No FDA-approved injectable thymosin beta-4 drug label. Human translational work exists, but product identity differs from commercial TB-500 fragments and no routine approved protocol exists.
- Content review status
- research reference